These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16951150)

  • 21. A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.
    Cheon DJ; Tong Y; Sim MS; Dering J; Berel D; Cui X; Lester J; Beach JA; Tighiouart M; Walts AE; Karlan BY; Orsulic S
    Clin Cancer Res; 2014 Feb; 20(3):711-23. PubMed ID: 24218511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
    Donninger H; Bonome T; Radonovich M; Pise-Masison CA; Brady J; Shih JH; Barrett JC; Birrer MJ
    Oncogene; 2004 Oct; 23(49):8065-77. PubMed ID: 15361855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
    Cardillo MR; Yap E; Castagna G
    J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Bandiera E; Rossi E; Donzelli C; Pasinetti B; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2007 Mar; 196(3):245.e1-11. PubMed ID: 17346539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells.
    Ranganathan P; Agrawal A; Bhushan R; Chavalmane AK; Kalathur RK; Takahashi T; Kondaiah P
    BMC Genomics; 2007 Apr; 8():98. PubMed ID: 17425807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression patterns that characterize advanced stage serous ovarian cancers.
    Lancaster JM; Dressman HK; Whitaker RS; Havrilesky L; Gray J; Marks JR; Nevins JR; Berchuck A
    J Soc Gynecol Investig; 2004 Jan; 11(1):51-9. PubMed ID: 14706684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
    Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
    Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
    Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
    Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
    Yamada SD; Baldwin RL; Karlan BY
    Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
    Kelley TJ; Elmer HL; Corey DA
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential gene expression identifies subgroups of ovarian carcinoma.
    Skubitz AP; Pambuccian SE; Argenta PA; Skubitz KM
    Transl Res; 2006 Nov; 148(5):223-48. PubMed ID: 17145569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma.
    Steg A; Wang W; Blanquicett C; Grunda JM; Eltoum IA; Wang K; Buchsbaum DJ; Vickers SM; Russo S; Diasio RB; Frost AR; LoBuglio AF; Grizzle WE; Johnson MR
    J Mol Diagn; 2006 Feb; 8(1):76-83. PubMed ID: 16436637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.